163 related articles for article (PubMed ID: 35850693)
1. Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice.
Choi HJ; Park JH; Jeong YJ; Hwang JW; Lee S; Lee H; Seol E; Kim IW; Cha BY; Seo J; Moon M; Hoe HS
Mol Brain; 2022 Jul; 15(1):63. PubMed ID: 35850693
[TBL] [Abstract][Full Text] [Related]
2. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
3. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
Batarseh YS; Kaddoumi A
J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
[TBL] [Abstract][Full Text] [Related]
4. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD.
Lee HJ; Nam J; Hwang JW; Park JH; Jeong YJ; Jang JY; Kim SJ; Jo AR; Hoe HS
Mol Brain; 2024 Apr; 17(1):21. PubMed ID: 38685105
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
7. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease.
Govindarajan K; Kar S
J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018
[TBL] [Abstract][Full Text] [Related]
8. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
9. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model.
Shin J; Park S; Lee H; Kim Y
Sci Rep; 2021 Jan; 11(1):1617. PubMed ID: 33452414
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease.
Lee HJ; Jeon SG; Kim J; Kang RJ; Kim SM; Han KM; Park H; Kim KT; Sung YM; Nam HY; Koh YH; Song M; Suk K; Hoe HS
Aging Cell; 2021 Mar; 20(3):e13332. PubMed ID: 33709472
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
Vergara C; Houben S; Suain V; Yilmaz Z; De Decker R; Vanden Dries V; Boom A; Mansour S; Leroy K; Ando K; Brion JP
Acta Neuropathol; 2019 Mar; 137(3):397-412. PubMed ID: 30599077
[TBL] [Abstract][Full Text] [Related]
12. (-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model.
Tajmim A; Cuevas-Ocampo AK; Siddique AB; Qusa MH; King JA; Abdelwahed KS; Sonju JJ; El Sayed KA
Nutrients; 2021 May; 13(5):. PubMed ID: 34069842
[TBL] [Abstract][Full Text] [Related]
13. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
15. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying treatment with I
Vasilopoulou F; Rodríguez-Arévalo S; Bagán A; Escolano C; Griñán-Ferré C; Pallàs M
Br J Pharmacol; 2021 Aug; 178(15):3017-3033. PubMed ID: 33817786
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice.
Gnoth K; Geissler S; Feldhaus J; Taudte N; Ilse V; Zürner S; Greiser S; Braumann UD; Rahfeld JU; Cynis H; Schilling S
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327591
[TBL] [Abstract][Full Text] [Related]
19. The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice.
Jeon SG; Lee HJ; Park H; Han KM; Hoe HS
Mol Brain; 2020 Sep; 13(1):131. PubMed ID: 32977842
[TBL] [Abstract][Full Text] [Related]
20. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
Ju Y; Tam KY
Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
